StockData
FMC Corp logo

FMC Corp (FMC) stock analysis

FMCNYSEChemicals & Allied ProductsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 30, 2026Score 6/30
$5.64+0.23 (+4.25%)

Close on Nov 10, 2026Market cap $877.35MP/E –Yield 32.27%

StockData Score

Prices as of Nov 11, 2026How the score works

Value1Growth0Performance0Health1Dividend4

Weak6 of 30 checks passed

FMC passes 6 of the 30 checks behind our score; 11 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.

Valuation
1/6
Growth
0/6
Past performance
0/6
Financial health
1/6
Dividend
4/6

What stands out

  • Covered by free cash flow

    Dividends take 27.9% of free cash flow.

  • P/S below the industry

    FMC's price-to-sales of 0.31 is below the Chemicals and Allied Products median of 1.28 (book value is negative, so we use sales).

  • Short-term assets cover short-term debts

    Current assets are 1.66 times current liabilities.

  • Pays a dividend

    FMC paid dividends worth 5.7% of the share price over the last twelve months.

What to watch

  • Return on equity under 15%

    Return on equity was -227% over the last twelve months and averaged 4.1% over five years; we look for 15% on both.

  • Return on capital under 10%

    Return on invested capital was -38.4%, below the 10% that usually covers the cost of capital.

  • Revenue growing under 10% a year

    Revenue grew -15.8% a year over the last three fiscal years, short of the 10% we look for.

  • Interest not well covered

    Operating income covers interest expense -10.0 times; we look for at least 5.

Valuation1/6
  • P/E against its history

    Not enough price and earnings history to compare.

  • P/E against the industry

    Needs positive earnings and enough profitable companies in the industry.

  • EV/EBITDA against its history

    Needs positive EBITDA and price history.

  • P/S below the industry

    FMC's price-to-sales of 0.31 is below the Chemicals and Allied Products median of 1.28 (book value is negative, so we use sales).

  • Price against fair value

    We could not estimate a fair value: it needs at least two valuation methods with positive inputs.

  • Margin of safety

    Depends on the fair value estimate.

Growth0/6
  • Revenue growing under 10% a year

    Revenue grew -15.8% a year over the last three fiscal years, short of the 10% we look for.

  • EPS growth over 3 years

    Needs positive EPS three years ago and today.

  • Earnings acceleration

    Needs positive net income now, a year ago and five years ago.

  • Growing slower than the industry

    Revenue grew -22.0% over the last twelve months; the Chemicals and Allied Products median is 0.1%.

  • Guidance lowered

    FMC lowered its Third-quarter Adjusted EBITDA outlook on Oct 15, 2026.

  • Gross margin slipping

    Gross margin was 22.0% over the last twelve months, against 38.1% a year earlier.

Past performance0/6
  • Return on equity under 15%

    Return on equity was -227% over the last twelve months and averaged 4.1% over five years; we look for 15% on both.

  • Return on capital under 10%

    Return on invested capital was -38.4%, below the 10% that usually covers the cost of capital.

  • Return on equity below the industry

    FMC's return on equity of -227% is below the Chemicals and Allied Products median of -3.8%.

  • Earnings over 5 years

    Needs positive net income five years ago and in the latest year.

  • Net margin below its 5-year average

    Net margin was -151% over the last twelve months, against a 5-year average of 0.1%.

  • Net margin below the industry

    FMC's net margin of -151% is below the Chemicals and Allied Products median of -2.8%.

Financial health1/6
  • Debt level

    Needs debt and equity figures.

  • Debt trend

    Needs a balance sheet from five years ago with positive equity.

  • Debt not well covered by cash flow

    Operating cash flow over the last twelve months equals 10.2% of total debt; we look for at least 20%.

  • Interest not well covered

    Operating income covers interest expense -10.0 times; we look for at least 5.

  • Short-term assets cover short-term debts

    Current assets are 1.66 times current liabilities.

  • Elevated bankruptcy risk

    The Altman Z-score is -0.19; above 3 is the safe zone and below 1.8 the distress zone.

Dividend4/6
  • Pays a dividend

    FMC paid dividends worth 5.7% of the share price over the last twelve months.

  • Yield above Treasuries

    The 5.7% yield is above the 4.4% on a 1-year Treasury.

  • Yield in the top quarter

    The top quarter of US dividend payers yield 3.8% or more; FMC yields 5.7%.

  • Dividend was cut

    The dividend per share fell by more than 10% at least once in the last 10 fiscal years.

  • Earnings cover

    Needs dividends paid and net income.

  • Covered by free cash flow

    Dividends take 27.9% of free cash flow.

Scores of similar companies

We don't publish a fair value for FMC. It needs a US-dollar share price, at least two valuation methods with positive inputs (earnings, EBITDA, book value or sales) and, for companies with several share classes, classes that trade at the same price.

Valuation over time

Using the earnings and balance sheet published at each date, not today's.

  • P/E at month end
  • Own 5-year median 16.8
  • Chemicals and Allied Products median 25.2

An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.

Market risk

From the past year of daily prices.

Liquidity

Low risk

Average value traded per day
$51.63M
Value traded per 1% price move
$11.18M

Downside

High risk

Typical loss in a bad month
47.6%
Volatility (annualized)
75%
Sharpe ratio, 1 year
-0.85
Beta to the S&P 500 (5Y)
0.80

Typical bad-month loss, week by week

25%: high

Margins

Share of revenue, fiscal years 2011 to 2025

Gross margin

37.0%−7.1 pts over 5 years

Operating margin

-47.0%−66.3 pts over 5 years

Net margin

-64.6%−76.5 pts over 5 years

See a number that looks wrong?